We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
National Research's Q4 Earnings Drop Y/Y, Stock Falls 9%
Read MoreHide Full Article
Shares of National Research Corporation (NRC - Free Report) have declined 9.1% since the company reported its earnings for the quarter ended Dec. 31, 2024. This compares to the S&P 500 index’s 0.6% decline over the same time frame. Over the past month, the stock has declined 7.4% compared with the S&P 500’s 0.4% growth.
See the Zacks Earnings Calendar to stay ahead of market-making news.
National Research reported earnings per share of 28 cents in the fourth quarter of 2024, down from 36 cents in the corresponding period last year.
The company reported revenues of $36.9 million for the fourth quarter of 2024, a decrease from $38 million in the prior-year quarter. Net income for the quarter declined to $6.6 million from $8.9 million in the year-ago quarter.
Total operating expenses increased to $27.3 million from $26.3 million, primarily driven by higher direct expenses and selling, general, and administrative (SG&A) costs. Operating income fell to $9.6 million from $11.7 million, reflecting the impact of higher costs and lower revenues.
National Research Corporation Price, Consensus and EPS Surprise
The company's total recurring contract value stood at approximately $133.2 million on Dec. 31, 2024. Net indebtedness (total borrowing minus cash and cash equivalents) was around $58.5 million at the end of the quarter.
Interest expenses increased to $0.7 million, up from $0.3 million in the prior-year quarter.
Factors Influencing Performance
Revenue declines and margin compression were key contributors to NRC’s lower earnings performance in the quarter. A modest increase in operating expenses, particularly in SG&A costs, weighed on profitability. Additionally, a significant rise in interest expenses further pressured net income.
Other Developments
During the quarter, NRC continued its capital allocation strategy through share repurchases and dividend distributions. NRC repurchased approximately 393,000 shares for around $7.3 million and paid a quarterly dividend of 12 cents per share, totaling approximately $2.8 million.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
National Research's Q4 Earnings Drop Y/Y, Stock Falls 9%
Shares of National Research Corporation (NRC - Free Report) have declined 9.1% since the company reported its earnings for the quarter ended Dec. 31, 2024. This compares to the S&P 500 index’s 0.6% decline over the same time frame. Over the past month, the stock has declined 7.4% compared with the S&P 500’s 0.4% growth.
See the Zacks Earnings Calendar to stay ahead of market-making news.
National Research reported earnings per share of 28 cents in the fourth quarter of 2024, down from 36 cents in the corresponding period last year.
The company reported revenues of $36.9 million for the fourth quarter of 2024, a decrease from $38 million in the prior-year quarter. Net income for the quarter declined to $6.6 million from $8.9 million in the year-ago quarter.
Total operating expenses increased to $27.3 million from $26.3 million, primarily driven by higher direct expenses and selling, general, and administrative (SG&A) costs. Operating income fell to $9.6 million from $11.7 million, reflecting the impact of higher costs and lower revenues.
National Research Corporation Price, Consensus and EPS Surprise
National Research Corporation price-consensus-eps-surprise-chart | National Research Corporation Quote
Other Key Business Metrics
The company's total recurring contract value stood at approximately $133.2 million on Dec. 31, 2024. Net indebtedness (total borrowing minus cash and cash equivalents) was around $58.5 million at the end of the quarter.
Interest expenses increased to $0.7 million, up from $0.3 million in the prior-year quarter.
Factors Influencing Performance
Revenue declines and margin compression were key contributors to NRC’s lower earnings performance in the quarter. A modest increase in operating expenses, particularly in SG&A costs, weighed on profitability. Additionally, a significant rise in interest expenses further pressured net income.
Other Developments
During the quarter, NRC continued its capital allocation strategy through share repurchases and dividend distributions. NRC repurchased approximately 393,000 shares for around $7.3 million and paid a quarterly dividend of 12 cents per share, totaling approximately $2.8 million.